共 355 条
[1]
Smith BD(2009)Future of cancer incidence in the United States: burdens upon an aging, changing nation J Clin Oncol Off J Am Soc Clin Oncol 27 2758-2765
[2]
Smith GL(2012)Under-representation of older adults in cancer registration trials: known problem, little progress J Clin Oncol Off J Am Soc Clin Oncol 30 2036-2038
[3]
Hurria A(2015)Geriatric assessment-identified deficits in older cancer patients with normal performance status Oncologist 20 379-385
[4]
Hortobagyi GN(1997)Cancer chemotherapy in older adults. A tolerability perspective Drugs Aging 10 34-49
[5]
Buchholz TA(2000)General guidelines for the management of older patients with cancer Oncology (Williston Park) 14 221-227
[6]
Scher KS(2018)Chemotherapy toxicity risk score for treatment decisions in older adults with advanced solid tumors Oncologist 23 573-579
[7]
Hurria A(2011)Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study J Clin Oncol Off J Am Soc Clin Oncol 29 3457-3465
[8]
Jolly TA(2018)Geriatric assessment: precision medicine for older adults with cancer Journal of oncology practice / American Society of Clinical Oncology 14 97-98
[9]
Deal AM(2016)The development of immunotherapy in older adults: new treatments, new toxicities? Journal of geriatric oncology 7 325-333
[10]
Nyrop KA(2003)Naive T cells are maintained by thymic output in early ages but by proliferation without phenotypic change after age twenty Immunol Cell Biol 81 487-495